Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review
Pleura and Peritoneum · 2016
DOI: 10.1515/pp-2016-0010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pleura and Peritoneum, 2016. Verfasst von Claramae Shulyn Chia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, National Cancer Centre Singapore, Singapore. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The current treatment of choice for peritoneal carcinomatosis from gastric cancer is systemic chemotherapy. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is a new aggressive form of loco-regional treatment that is currently being used in pseudomyxoma peritoneii, peritoneal mesothelioma and peritoneal carcinomatosis from colorectal cancer. It is still under investigation for its use in gastric cancer.
Methods
The literature between 1970 and 2016 was surveyed systematically through a review of published studies on the treatment outcomes of CRS and HIPEC for peritoneal carcinomatosis from gastric cancer.
Results
Seventeen studies were included in this review. The median survival for all patients ranged from 6.6 to 15.8 months. The 5-years overall survival ranged from 6 to 31%. For patients with complete cytoreduction, the median survival was 11.2 to 43.4 months and the 5-years overall survival was 13 % to 23%. Important prognostic factors were found to be a low peritoneal carcarcinomatosis index (PCI) score and the completeness of cytoreduction.
Conclusion
The current evidence suggests that CRS and HIPEC has a role to play in the treatment of peritoneal carcinomatosis from gastric cancer. Long term survival has been shown for a select group of patients. However, further studies are needed to validate these results.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgical Oncology, National Cancer Centre Singapore, Singapore.
- Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India.
Zitieren
APA
Chia, C. S., Seshadri, R. A., Kepenekian, V., Vaudoyer, D., Passot, G., & Glehen, O. (2016). Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review. Pleura and Peritoneum. https://doi.org/10.1515/pp-2016-0010
Vancouver
Chia CS, Seshadri RA, Kepenekian V, Vaudoyer D, Passot G, Glehen O. Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review. Pleura and Peritoneum. 2016. doi:10.1515/pp-2016-0010
BibTeX
@article{Chia2016,
author = {Chia, Claramae Shulyn and Seshadri, Ramakrishnan Ayloor and Kepenekian, Vahan and Vaudoyer, Delphine and Passot, Guillaume and Glehen, Olivier},
title = {Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review},
journal = {Pleura and Peritoneum},
year = {2016},
doi = {10.1515/pp-2016-0010}
}
EUVIMED